PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Harpoon Therapeutics, Inc. (HARP)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US41358P1066

CUSIP

41358P106

Sector

Healthcare

IPO Date

Feb 8, 2019

Highlights

Market Cap

$492.35M

EPS (TTM)

-$8.62

Year Range

$22.93 - $23.21

Target Price

$24.79

Short %

3.24%

Short Ratio

0.37

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Harpoon Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


HARP (Harpoon Therapeutics, Inc.)
Benchmark (^GSPC)

Returns By Period


HARP

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.22%

1M

2.22%

6M

9.51%

1Y

22.46%

5Y*

12.74%

10Y*

11.29%

*Annualized

Monthly Returns

The table below presents the monthly returns of HARP, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202496.39%2.73%102.37%
202348.82%-28.30%-3.90%-21.38%16.22%4.41%10.32%32.77%-61.25%25.06%110.32%7.26%56.68%
2022-29.93%-22.50%21.22%-54.73%-8.44%-7.28%2.09%-14.87%-41.56%-5.80%-25.03%5.93%-90.39%
202116.07%0.05%8.45%8.22%-8.92%-32.74%-29.42%-3.17%-16.67%-20.76%-1.92%22.96%-54.55%
2020-10.14%15.43%-24.51%8.81%72.70%-23.71%-33.67%24.98%23.47%-14.83%3.11%11.33%12.31%
201912.37%-37.57%23.97%2.47%8.06%14.54%-2.75%-5.66%-2.64%40.60%-20.91%9.56%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 94, HARP is among the top 6% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of HARP is 9494
Overall Rank
The Sharpe Ratio Rank of HARP is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of HARP is 9595
Sortino Ratio Rank
The Omega Ratio Rank of HARP is 9595
Omega Ratio Rank
The Calmar Ratio Rank of HARP is 9595
Calmar Ratio Rank
The Martin Ratio Rank of HARP is 9292
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Harpoon Therapeutics, Inc. (HARP) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
HARP
^GSPC

There is not enough data available to calculate the Sharpe ratio for Harpoon Therapeutics, Inc.. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio
HARP (Harpoon Therapeutics, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Harpoon Therapeutics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


HARP (Harpoon Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Harpoon Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Harpoon Therapeutics, Inc. was 98.67%, occurring on Oct 10, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.67%May 27, 2020850Oct 10, 2023
-47.81%Dec 26, 201955Mar 16, 202047May 21, 2020102
-44.33%Mar 5, 201919Mar 29, 2019115Sep 12, 2019134
-25.93%Sep 13, 201928Oct 22, 201926Nov 27, 201954
-14.06%Feb 25, 20191Feb 25, 20195Mar 4, 20196

Volatility

Volatility Chart

The current Harpoon Therapeutics, Inc. volatility is 1.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


HARP (Harpoon Therapeutics, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Harpoon Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Harpoon Therapeutics, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab